You have successfully logged out.


March 31, 2021

B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc., and Infraredx, a Nipro Company, Announce Strategic U.S. Collaboration to Execute the IDE Clinical Trial for the SeQuent® Please ReX™ Drug Coated PTCA Balloon Catheter

Following Receipt of FDA Breakthrough Device Designation, Market Leading Global Organizations Strengthen their Cooperation to Navigate U.S. Regulatory Pathway

[1] Moussa ID et al. JACC. 2020; 76(13): 1522-1531.

[2] Scheller B et al. JACC. 2020 ; 75(9): 1017-1028.